the Effect of Ardeh Consumption on Heat-shock Protein Antibodies in Type 2 Diabetic Patients

Survey the Effect of Ardeh Consumption on Heat-shock Protein Antibody Titers in Type 2 Diabetic Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016011726048N1

Enrollment

Registered

2016-03-19

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. E11

Interventions

Intervention 1: The intervention group received 40 grams of Ardeh as a part of breakfast for 8 weeks. Intervention 2: control group will receive regular breakfast for 8 weeks.

Lifestyle

The intervention group received 40 grams of Ardeh as a part of breakfast for 8 weeks

control group will receive regular breakfast for 8 weeks.

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:(people with type 2 diabetes, according to the America Diabetes Association diagnostic criteria; age 60-30 years) Exclusion criteria:(pregnancy or lactation; insulin therapy; systemic disease; over 60 years old or under 30 years; unwillingness to continue cooperation)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Heat-shock Protein Antibody Titers. Timepoint: before intervention and after intervention. Method of measurement: Based on blood tests using ELISA method (ng / ml).	—

Secondary

Measure	Time frame
Fasting blood sugar. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;Total cholestrol. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;Blood triglyceride. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;LDL.C. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;HDL.C. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;Hs- CRP. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).	—

Measure

Time frame

Fasting blood sugar. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;Total cholestrol. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;Blood triglyceride. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;LDL.C. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;HDL.C. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).;Hs- CRP. Timepoint: before and after intervention. Method of measurement: Based on laboratory measurements (milligrams per deciliter).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Parsanahad

Ahvaz Jundishapur University of Medical Sciences

info@ajums.ac.ir+98 61 3571 2639

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026